Nanolytics Overview
- Founded
- 1999
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
Nanolytics General Information
Description
Provider of nano-droplet microfluidics. The company provides proprietary novel technologies like microfluidics which can be used for fabricating bio-chips, used for analyzing biological and environmental samples.
Contact Information
Primary Industry
Biotechnology
Acquirer
Primary Office
- 5905 Triangle Drive
- Raleigh, NC 27617
- United States
Nanolytics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Merger/Acquisition | 27-Feb-2007 | 00000 | Completed | Generating Revenue | ||
| 4. Angel (individual) | 00000 | 00000 | Completed | Generating Revenue | ||
| 3. Grant | 01-Jan-2006 | 00000 | Completed | Generating Revenue | ||
| 2. Grant | 01-Jan-2004 | $117K | Completed | Startup | ||
| 1. Grant | 01-Jan-2000 | $300K | Completed | Startup |
Nanolytics Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Alexander Shenderov Ph.D | Chief Technology Officer & Co-Founder | ||
| Varvara Grichko Ph.D | Co-Founder |
Nanolytics Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| U.S. Department of Health and Human Services | Government | 000 0000 | 000000 0 |